Bayer Receives FDA Approval for
Selected Abstract
Bayer Receives FDA Approval for VERSANT(R) HIV bDNA Viral Load System; - Assay Generates More Confident Results for Physicians and Patients -.
TARRYTOWN, N.Y. -- Bayer Diagnostics announced today that it received US Food and Drug Administration approval for VERSANT(R) HIV-1 RNA 3.0 Assay (bDNA its nucleic acid probe diagnostic assay for the direct quantification of HIV-1 RNA in the plasma of people living with HIV. VERSANT(R) HIV bDNA is ... September 17, 2002; PR Newswire
Read the full article with a free-trial membership at HighBeam Research
Related Articles 1.
Bayer Receives FDA Approval For Versant(R) HIV bDNA Viral Load System.
2.
Bayer Receives FDA Approval for Room Temperature Storage of Kogenate(R) FS; Extended Storage Labeling Provides Greater Flexibility for Individuals Living with Hemophilia A.
3.
Bayer Receives FDA Approval for VERSANT(R) HIV bDNA Viral Load System; - Assay Generates More Confident Results for Physicians and Patients -.
4.
Bayer Receives FDA Approval for the Intravenous Form of Its Antibiotic Avelox(R) (moxifloxacin HCl).
|
